Scholler N
No ORCID on file
· 5 papers in corpus
· active 2004-2012
Top journals
Frequent coauthors
- Urban N 3
- Coukos G 2
- McIntosh MW 2
- Bergan LA 1
- Cramer DW 1
- Drescher C 1
- DeAngelis RA 1
- Drescher CW 1
- Forrest RM 1
- Connolly DC 1
2012
Complement activation plays a critical role in controlling inflammatory responses. To assess the role of complement during ovarian cancer progression, we crossed two strains of mice with genetic complement deficiencies with transgenic mice …
2011
In screening for epithelial ovarian cancer, unnecessary surgery can be reduced by limiting use of transvaginal ultrasound (TVU) to women with increasing CA125 serum levels. Replacing or augmenting TVU with measurement of a serum marker spec…
2009
Ovarian cancer (OC) is the fourth leading cause of cancer deaths among women in the United States, despite its relatively low incidence of 50 per 100,000. Even though advances in therapy have been made, the OC fatality-to-case ratio remains…
2007
A quarter of a century since its discovery, circulating CA125 antigen is recommended for clinical use in the USA for ovarian cancer screening of high-risk women with ovaries, despite its limited sensitivity and specificity. Recent findings …
2004
ObjectivesThe serum tumor marker CA 125 is elevated in most clinically advanced ovarian carcinomas. Because these elevations may precede clinical detection by a year or more, CA 125 is potentially useful for early detection as part of an ov…